[2] [16] Some patients have reported subjective feelings of anxiety or mood alterations while taking tirzepatide, though these reports are anecdotal and have not been systematically validated in controlled studies
GLP-1 medications work through hormonal pathways that influence hunger, fullness, and calorie intake, addressing biological factors that lifestyle changes alone may not fully overcome
Many patients report increased hunger and reduced fullness after meals as the medication's effects wear off, though the timing varies between individuals
Glucagon and glucagon-like peptide-1 as novel anti-inflammatory and immunomodulatory compounds
Price Target Summary From $1,062 Peak to a Buyable Pullback Lilly is down 12.89% year to date after peaking near $1,062 in December 2025, yet shares jumped 9.8% on April 30 following a blockbuster Q1 earnings report